Previous close | 5.80 |
Open | 5.75 |
Bid | 5.65 x 200000 |
Ask | 5.95 x 150000 |
Day's range | 5.75 - 5.75 |
52-week range | 2.10 - 6.40 |
Volume | |
Avg. volume | 34 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won't get...
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cipher Pharmaceuticals Inc. (TSX: CPH; OTCQX: CPHRF), a specialty pharmaceutical company, has qualified to trade on the OTCQX® Best Market. Cipher Pharmaceuticals Inc. upgraded to OTCQX from the Pink® market. Cipher Pharmaceuticals Inc. begins trading today on OTCQX under the symbol “CPHRF.” U.S. investors can find c
Key Insights Cipher Pharmaceuticals' significant individual investors ownership suggests that the key decisions are...